Record revenue and profitability driven by subscription growth and OEM expansion.

Phase III trial shows 91 more catheter-free days for dialysis patients.

Captivate acquisition expands footprint into office and residential advertising networks.

Revenue hit $142.8M with 21.9% organic growth as AI-focused verticals accelerated.

Net income surged 24% while voluntary market policies hit record highs.

Same-location NOI surged 12% as utilization climbed to 70%.

Revenue hit $250.1 million as G2_Austin construction advances toward Q1 2027 production.

Premium shift drives margin expansion amid traffic headwinds.

Wrangler gains market share for 17th straight quarter as Helly Hansen grows.

Revenue surpassed $1 billion for the first time amid Joe Hudson's integration.

GBS and geographic atrophy programs advance toward 2026-2027 regulatory submissions.

Prescription growth surged 45% in July after telehealth launch.

Revenue jumped 36% sequentially as defense and drone opportunities emerge.

Biotech extends runway to 2028 with $100M financing and Eli Lilly deal.

Lithium prices surged to $19,563 per tonne, driving 70% margins and $141M free cash flow.

Revenue surged 48.7% YoY as margins expanded and government contracts grew.

Chili's same-store sales surged 5.6% as Big Crispy sandwich sales tripled post-launch.

CEO Latimer says Fervo may be the only way to get clean firm power before 2030.

YUTREPIA sales hit $170.4 million with 5,000+ patients started on therapy.

India bookings surge to $120 million year-to-date as competitive pressures ease.

CEO Jackson warns demand trends have disappointed as company cuts full-year guidance.

Foodservice equipment maker reports 9.9% sales growth and raises guidance.

Company returns to profitability on restructuring gains and surging customer orders.

Record profit despite volatile commodity markets and cautious consumer spending.

McPherson discusses market share gains despite negative restaurant foot traffic.

Revenue grew 11% to $972 million as ARR climbed 14% to $2.51 billion.

GMV surged 44% to $2.089 billion as adjusted EBITDA margins expanded 300 basis points.

CARDAMYST prescriptions surged fourfold as insurance coverage doubled to 50%.

CEO Ryan Caswell discusses asset sales, SpaceX gains, and sports portfolio expansion.

CEO Heller discusses nuclear energy expansion and $32 billion pending awards pipeline.

NHI completes $560M portfolio sale and accelerates senior housing expansion strategy.

Attruby revenue surged to $222.4 million as three pipeline programs entered regulatory review.